Are you using any molecular allergen diagnostics for predicting the long-term outcomes of venom-specific immunotherapy and as guidance to stop VIT?

At the moment, we are not. Component-resolved diagnostics (CRD) for venom have been widely available in Europe for some time and were approved by US Food and Drug Administration for venom allergy diagnosis in April 2020. The primary use for CRD will likely be in differentiating patients who are trul...